Cyclopharm Limited

ASX:CYC ISIN:AU000000CYC5

The Company produces and supplies the medical profession with proprietary lung radiopharmaceuticals.  
 

News

Cyclopharm Limited (ASX:CYC) Important Milestones in Nuclear Medicine

🕔5/29/2013 11:41:30 PM 11406

Cyclopharm Limited (ASX:CYC) is an Australian-based company manufacturing and selling nuclear medicine equipment, radiopharmaceuticals and related research and development services. The company specializes in imaging of lungs (Technegas system) and molecular imaging radiopharmaceuticals used in cancer, brain and cardiac imaging.

Read Full Article

Cyclopharm Limited ASX: CYC - Half Year Presentation - Mr John Sharman, MD

🕔8/30/2007 2:09:00 PM 3474

Cyclopharm Limited (ASX: CYC) - Half Year Presentation - Mr John Sharman, MD; Cyclopharm Limited (ASX: CYC) present the following audio webcast regarding "Half Year Presentation". You may also download this audio webcast to your computer or portable audio player.

Read Full Article

Cyclopharm Limited ASX: CYC - 2007 AGM Summary - Mr John Sharman, MD

🕔5/14/2007 1:58:00 PM 3781

Cyclopharm Limited [B@1d2a07e; Boardroomradio is pleased to announce that Cyclopharm Limited (ASX: CYC) has published an audio file.

Read Full Article
###

4,585 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 6) (Last 30 Days: 26) (Since Published: 4585) 

Company Data

    Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Healthcare 

More News Results

  • 2024/10/03: CYC Signs Agreement with VA and First DoD Order Received*
  • 2024/10/01: Change of Director's Interest Notice - JW*
  • 2024/09/03: Cyclopharm - 2024 First Half Results & USA Expansion Update*
  • 2024/08/29: Webinar - 1H2024 Results and USA update*
  • 2024/08/27: Cyclopharm 2024 H1 Trading and USA Expansion Update*
  • 2024/08/27: Half Yearly Report and Accounts*
  • 2024/06/28: Cleansing Notice*
  • 2024/06/28: Application for quotation of securities - CYC*
  • 2024/06/28: Proposed issue of securities - CYC*
  • 2024/06/28: Change of Director's Interest Notice - KB*
*refer to company website